Biochemical superglue opens new approach to vaccine development according to : phys

Explore further: Synthetic biologists use bacterial superglue for faster vaccine development The commercialisation of SpyBiotech's technology and company formation is supported by Oxford University Innovation, the research commercialisation company of Oxford University. SpyBiotech believes that this bond is the missing link to effective development and production of highly effective vaccines. Credit: University of Oxford An Oxford University spinout company is developing a molecular superglue for the rapid development of vaccines targeting a range of diseases. We view this superglue technology as a game changer to enable faster development of effective vaccines against major global diseases.




Some Iowa students will be required to get a meningococcal vaccine effective next school year, health officials say. The Department of Public Health said in a news release that the requirement was made in the 2016 legislative session, making Iowa one of 32 states with a meningococcal vaccine school requirement. "Parents and guardians should check their child's immunization records," Rick Kozin, Polk County Health Department director, said in a statement. For more information about the meningococcal vaccine, visit www.polkcountyiowa.gov/health. AdvertisementSeventh and 12th-grade students will have to receive a proof of vaccination form from their doctor or present a certificate of exemption at the start of the 2017/2018 academic school year.

As Nigeria Meningitis death toll grows, Kenya gets new vaccine to prepare for outbreak

"The meningitis Vaccine will therefore offer long-term immunity against the disease to high risk populations," Achary said. She added that a partnership with the ministry of health will facilitate distribution of the Meningitis vaccine to the high risk counties. Related NewsKenya on Friday unveiled meningitis vaccine as the debilitating bacterial disease threatens to break out in the country's northern counties amid biting drought. Deshnee Achary, the head of Pfizer Vaccines in the Anglophone region, said Kenya became the first country in the region to benefit from a meningitis vaccine that was developed after rigorous scientific research. Experts say Nigeria has been hit by a new strain of the disease, which has no commercially available vaccine.


collected by :Lucy William

To follow all the new news about Health care